Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Icotrokinra in biologic-experienced participants with active psoriatic arthritis is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Icotrokinra (JNJ-77242113)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Psoriatic | Phase 3 | Status: RECRUITING